Welcome Back
Join CoinTime
Sign in with email
Sign up with email
Check your inbox
Molecular Assemblies
About
Molecular Assemblies is developing a revolutionary, enzymatic DNA synthesis technology capable of powering new products.
- 1 - 10
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $25.80M
- Industries
- Biotechnology,Genetics,Health Care
- Founded date
- Jan 1, 2013
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Molecular Assemblies is a San Diego-based company developing a revolutionary, enzymatic DNA synthesis technology capable of powering new products in industrial synthetic biology, personalized therapeutics, precision diagnostics, and eventually information storage, nanotechnology and more. Inspired by nature, the company’s proprietary DNA synthesis method is designed to produce long, high quality, sequence-specific DNA reliably, affordably and sustainably. With a highly experienced executive and scientific team and an expansive intellectual property portfolio, Molecular Assemblies has attracted investments from Agilent Technologies, Cavendish Impact Capital Fund, Data Collective Venture Capital, Eleven Two Capital, Genomics Investment Syndicate, Keshif Ventures, Newport Holdings, LP, and Alexandria Venture Investments.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 15, 2022 | Series B | $25.80M | 2 | — | — | Detail |
| Nov 4, 2021 | Series B | $10M | 1 |
|
— | Detail |
| Oct 19, 2021 | Grant | $250K | 1 |
National Human Genome Research Institute
|
— | Detail |
| Apr 15, 2021 | Series A | $11.80M | 2 | — | — | Detail |
| Oct 1, 2019 | Series A | $12.20M | 1 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series B |
|
National Human Genome Research Institute
|
Yes | Grant |
National Science Foundation
|
Yes | Grant |
Agilent Technologies
|
— | Series B |
Codexis
|
— | Series B |
|
|
— | Seed |
